Perkin Elmer strengthens OneSource with C&A purchase

Perkin Elmer announced it had acquired U.K.-based Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and management maintenance company serving the life science industry.
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
BOSTON—Perkin Elmer Inc. announced early last month it had acquired U.K.-based Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and management maintenance company serving the life science industry. Specific terms of the deal, including the purchase price for C&A, which booked sales of roughly $7.5 million in 2005, were not disclosed.
Continue reading below...
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
WebinarsAdvancing predictive in vitro models
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.
Read More
With the acquisition complete, the C&A staff will be folded into PerkinElmer's existing laboratory service offering called OneSource. The deal also highlights a con­tinuing trend among life science operations around the world—the outsourcing of labora­tory equipment maintenance and manage­ment, a market that PerkinElmer estimates to be more $2.5 billion annually.
"Our customers are feeling a lot of pres­sure these days to be more productive in their operations," says Dusty Tenney, VP and GM for laboratory services for PerkinElmer's OneSource. "Taking this time-consuming activity out of their hands allows them to spend more time on science and increase the productivity in the lab."
The acquisition of C&A, while not a huge player in the market, is a good strategic fit Tenney says because of its existing relation­ships with significant players in pharmaceu­tical and biotech companies, working rela­tionships with a broad network of indepen­dent service providers (ISPs) and because of its strong growth curve.
Continue reading below...
3D illustration of ciliated cells, with cilia shown in blue.
Application NoteMapping the hidden proteome of elusive organelles
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Read More
"This is a proven solution for cost reduc­tion and increased service levels which can be used to consolidate the management of a wide portfolio of equipment mod­els found in a typical laboratory environment into a single mainte­nance program," says Ken Caskie, managing director of C&A.
Indeed, one attractive aspect of C&A to PerkinElmer, Tenney notes, was its broad-based knowl­edge of a number of different OEM platforms both internal and via its network of ISPs with specific knowl­edge of a variety of diverse instru­ment platforms.
PerkinElmer's OneSource ser­vice solution was launched in early 2003, though the company had been providing contract lab management work for a number of years prior to that. Services range from simple periodic instrument maintenance agreements up to and including having PerkinElmer managers and engineers working on site to ensure optimal labora­tory management.

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue